Results 281 to 290 of about 285,474 (314)

Efficacy, safety and clinical pharmacology of macitentan in comparison to other endothelin receptor antagonists in the treatment of pulmonary arterial hypertension

Expert Opinion on Drug Safety, 2014
J. Dingemanse, P. Sidharta, W. Maddrey, L. Rubin, Hani Mickail   +4 more
semanticscholar   +1 more source

Breast cancer statistics, 2019

Ca-A Cancer Journal for Clinicians, 2019
Carol E Desantis, Jiemin, Mia M Gaudet
exaly  

Endothelin Receptor Antagonists

2001
J. D. Elliott, J.-N. Xiang
openaire   +1 more source

Endothelin receptor antagonists

2016
openaire   +2 more sources

Endothelin Receptor Antagonist

2020
openaire   +1 more source

Endothelin-receptor-antagonists/epoprostenol

Reactions Weekly, 2023
openaire   +1 more source

Endothelin Receptor Antagonists

2017
M Somasundaram, C Elamaran
openaire   +1 more source

Evolving standards of care and new challenges in the management of HER2‐positive breast cancer

Ca-A Cancer Journal for Clinicians, 2020
Grace M Choong, Grace D Cullen, Ciara C O'sullivan   +2 more
exaly  

Clinical Pharmacokinetics and Drug‐Drug Interactions of Endothelin Receptor Antagonists in Pulmonary Arterial Hypertension

Journal of clinical pharmacology, 2012
J. Venitz, J. Zack, H. Gillies, M. Allard, J. Regnault, C. Dufton   +5 more
semanticscholar   +1 more source

Breast cancer statistics, 2017, racial disparity in mortality by state

Ca-A Cancer Journal for Clinicians, 2017
Carol E Desantis, Ann Goding Sauer Msph, Lisa A Newman   +2 more
exaly